Log in to save to my catalogue

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without in...

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1273341680

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse

About this item

Full title

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.105-114

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Anti-thymocyte globulin (ATG) is polyclonal, containing Ab specificities capable of binding to various immune-cell subsets implicated in the pathogenesis of GVHD, including T cells, B cells, natural killer cells, monocytes/macrophages, neutrophils and DC. We wished to determine which ATG specificities are important for GVHD prevention. We measured...

Alternative Titles

Full title

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1273341680

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1273341680

Other Identifiers

ISSN

0268-3369

E-ISSN

1476-5365

DOI

10.1038/bmt.2012.99

How to access this item